Search - tctmd.com

Displaying 821 - 840 of 1038

Sort: Relevancy | Date

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Industry News

Medtronic Announces Global Drug-Eluting Balloon Study

April 17, 2012

News Industry News

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 09, 2012

News Daily News

Debate Continues on PCI Readmissions, Focus Shifts to Hospital Variation

Yael L. Maxwell

April 06, 2012

News Daily News

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

April 05, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Jason Kahn

April 03, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Caitlin E. Cox

March 30, 2012

News Daily News

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Caitlin E. Cox

March 30, 2012

News Daily News

Action Plan to Optimize Radiation Safety of Cardiovascular Imaging Developed

March 29, 2012

News Industry News

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

March 27, 2012

News Conference News ACC 2012

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

L.A. McKeown

March 26, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Industry News

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

March 26, 2012

News Daily News

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Yael L. Maxwell

March 15, 2012

News Daily News

Se Publica el TARGET-CABG: El Período de Espera al CABG depende de la Prueba de la Función Plaquetaria

Yael L. Maxwell

March 15, 2012

News Daily News

CLOSURE I Published as Similar PFO Trials Forge Ahead

Caitlin E. Cox

March 15, 2012

News Daily News

Interdisciplinary Approach Needed for Cardiac Stem Cell Therapy to Move Forward

Yael L. Maxwell

March 08, 2012

News Daily News

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

L.A. McKeown

March 06, 2012

Advertisement

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

TAVR Suitable Even in Patients with Impaired LVEF

Medtronic Announces Global Drug-Eluting Balloon Study

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

Debate Continues on PCI Readmissions, Focus Shifts to Hospital Variation

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Action Plan to Optimize Radiation Safety of Cardiovascular Imaging Developed

Data Presented at ACC.12 Demonstrate that OrbusNeich’s Genous™ Stent is Feasible and Safe in STEMI Patients

Two Studies Highlight Safety, Efficacy of Biodegradable Polymer SES

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Se Publica el TARGET-CABG: El Período de Espera al CABG depende de la Prueba de la Función Plaquetaria

CLOSURE I Published as Similar PFO Trials Forge Ahead

Interdisciplinary Approach Needed for Cardiac Stem Cell Therapy to Move Forward

Study Refutes Venous Hypothesis in Multiple Sclerosis, Weakening Argument for Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content